Shenzhen Chipscreen Biosciences Co Institutionelles Eigentum

Was ist das Institutionelles Eigentum von Shenzhen Chipscreen Biosciences Co?

Institutionelles Eigentum von Shenzhen Chipscreen Biosciences Co., Ltd. ist 7.43%

Was ist die Definition von Institutionelles Eigentum?



Institutionelles Eigentum ist der Betrag der verfügbaren Aktien eines Unternehmens, das sich im Besitz von Investmentfonds oder Pensionskassen, Versicherungsgesellschaften, Wertpapierfirmen, Stiftungen oder anderen großen Körperschaften befindet, die Fonds für Dritte verwalten.

Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.

Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.

Institutionelles Eigentum von Unternehmen in Health Care Sektor auf SSE im Vergleich zu Shenzhen Chipscreen Biosciences Co

Was macht Shenzhen Chipscreen Biosciences Co?

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Unternehmen mit institutionelles eigentum ähnlich Shenzhen Chipscreen Biosciences Co